NVOS logo

Novo Integrated Sciences (NVOS) Stock

Profile

Full Name:

Novo Integrated Sciences, Inc.

Sector:

Healthcare

Country:

United States

IPO:

23 February 2021

Indexes:

Not included

Description:

Novo Integrated Sciences (NVOS) focuses on providing innovative solutions in healthcare and technology. The company develops products and services that improve health outcomes and enhance patient care, aiming to integrate advanced science with practical applications for better living and well-being.

Events Calendar

Earnings

Next earnings date:

Feb 05, 2025

Recent quarterly earnings:

July 19, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 07, 2023

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results
Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results
Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results
NVOS
businesswire.com18 December 2024

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results.

Novo Integrated Sciences' Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million
Novo Integrated Sciences' Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million
Novo Integrated Sciences' Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million
NVOS
businesswire.com06 June 2024

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company's Board of Directors has approved an increase of up to $10 million maximum amount, from the previously announced up to $5 million maximum amount, for the repurchase of the Company's outstanding common stock from time to time in the open market at prevailing market prices or in privately negotiated transactions. The increased maximum amount available for purchase.

Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products
Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products
Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products
NVOS
businesswire.com05 June 2024

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that its wholly owned Canadian subsidiary, Acenzia Inc. (“Acenzia”), has been selected by Protein Industries Canada to participate in a new project to bring new protein products with a superior nutritional amino acid profile to the global marketplace. The total project is expected to see approximately $5.4 million invested into the development, reformulation, and commerciali.

Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note
Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note
Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note
NVOS
businesswire.com03 June 2024

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today the Company and RC Consulting Consortium Group LLC, in favor of SCP Tourbillion Monaco (“RC”), have amended the prepayment terms and conditions of the previously disclosed $70,000,000 promissory note, dated April 26, 2023 (the “RC Note”) to provide that, at any time after 12 months and no later than 60 months from the commencement of the term of the RC Note and prior to an e.

Novo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program
Novo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program
Novo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program
NVOS
businesswire.com31 May 2024

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program.

Novo Integrated stock more than doubles after hours on $1 billion collateral agreement
Novo Integrated stock more than doubles after hours on $1 billion collateral agreement
Novo Integrated stock more than doubles after hours on $1 billion collateral agreement
NVOS
Market Watch28 September 2023

Novo Integrated Sciences Inc. NVOS shares more than doubled in the extended session Thursday after the tiny healthcare company said it or entered a $1 billion funding agreement for the next 15 years. Novo Integrated shares soared as much as 155% after hours, following a 15.4% decline to close at 20 cents, giving the company a market capitalization of $31.8 million at the end of the trading day.

NVOS Stock Alert: Novo Seeks Approval for a Reverse Stock Split
NVOS Stock Alert: Novo Seeks Approval for a Reverse Stock Split
NVOS Stock Alert: Novo Seeks Approval for a Reverse Stock Split
NVOS
InvestorPlace21 August 2023

It's been quite a week for investors in Novo Integrated Sciences (NASDAQ: NVOS ). Shares of NVOS stock traded at less than 7 cents apiece to start last week but surged as high as 23 cents on Wednesday on a number of key business updates.

Why Is Novo Integrated Sciences (NVOS) Stock Up 60% Today?
Why Is Novo Integrated Sciences (NVOS) Stock Up 60% Today?
Why Is Novo Integrated Sciences (NVOS) Stock Up 60% Today?
NVOS
InvestorPlace15 August 2023

Novo Integrated Sciences (NASDAQ: NVOS ) stock is skyrocketing on Tuesday, enlivening a down session on Wall Street amid global economic concerns. Ironically, the news that's bolstering NVOS stock features some strong international overtones, with Novo entering a joint venture (JV) agreement with Canada's Farm 7 Group to implement the Kenya Agricultural Cooperative Project.

3 Strategies for Making Money With Penny Stocks in 2023
3 Strategies for Making Money With Penny Stocks in 2023
3 Strategies for Making Money With Penny Stocks in 2023
NVOS
PennyStocks27 March 2023

Can these strategies help you make money with penny stocks? The post 3 Strategies for Making Money With Penny Stocks in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Main Differences Between Penny Stocks & Blue Chips
Main Differences Between Penny Stocks & Blue Chips
Main Differences Between Penny Stocks & Blue Chips
NVOS
PennyStocks25 March 2023

Here's what you need to know about investing in penny stocks right now The post Main Differences Between Penny Stocks & Blue Chips  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

FAQ

  • What is the primary business of Novo Integrated Sciences?
  • What is the ticker symbol for Novo Integrated Sciences?
  • Does Novo Integrated Sciences pay dividends?
  • What sector is Novo Integrated Sciences in?
  • What industry is Novo Integrated Sciences in?
  • What country is Novo Integrated Sciences based in?
  • When did Novo Integrated Sciences go public?
  • Is Novo Integrated Sciences in the S&P 500?
  • Is Novo Integrated Sciences in the NASDAQ 100?
  • Is Novo Integrated Sciences in the Dow Jones?
  • When was Novo Integrated Sciences's last earnings report?
  • When does Novo Integrated Sciences report earnings?

What is the primary business of Novo Integrated Sciences?

Novo Integrated Sciences (NVOS) focuses on providing innovative solutions in healthcare and technology. The company develops products and services that improve health outcomes and enhance patient care, aiming to integrate advanced science with practical applications for better living and well-being.

What is the ticker symbol for Novo Integrated Sciences?

The ticker symbol for Novo Integrated Sciences is NASDAQ:NVOS

Does Novo Integrated Sciences pay dividends?

No, Novo Integrated Sciences does not pay dividends

What sector is Novo Integrated Sciences in?

Novo Integrated Sciences is in the Healthcare sector

What industry is Novo Integrated Sciences in?

Novo Integrated Sciences is in the Medical Care Facilities industry

What country is Novo Integrated Sciences based in?

Novo Integrated Sciences is headquartered in United States

When did Novo Integrated Sciences go public?

Novo Integrated Sciences's initial public offering (IPO) was on 23 February 2021

Is Novo Integrated Sciences in the S&P 500?

No, Novo Integrated Sciences is not included in the S&P 500 index

Is Novo Integrated Sciences in the NASDAQ 100?

No, Novo Integrated Sciences is not included in the NASDAQ 100 index

Is Novo Integrated Sciences in the Dow Jones?

No, Novo Integrated Sciences is not included in the Dow Jones index

When was Novo Integrated Sciences's last earnings report?

Novo Integrated Sciences's most recent earnings report was on 19 July 2024

When does Novo Integrated Sciences report earnings?

The next expected earnings date for Novo Integrated Sciences is 5 February 2025